Qatar Cancer Society (QCS) has launched an electronic collection system at 21 sites across the country, to make donations easier.
Donations are one of the most important sources of QCS to treat patients who are unable to afford the treatment as well as to support its programmes to spread awareness of cancer.
QCS general manager Mariam al-Noaimi stressed the importance of the donation in financial and moral support for cancer patients and combating cancer. She also called up on all parties to join hands to raise awareness of the disease and contribute to patients’ treatment.
In addition, some collection sites have been provided with screens to display awareness videos about cancer and promote early detection. In the next phase, such screens are to be installed at all collection sites.
She noted that collection sites include several projects licensed by Regulatory Authority for Charitable Activities for the treatment of cancer patients under license No 6/2017, and cancer awareness programmes under license No 7/2017.

In conjunction with the launch of the electronic collection system, a course was organised to develop the skills of cancer awareness promoters. They were trained in various marketing methods for collection, as well as all the cultural aspects and awareness of cancer.
Al-Noaimi referred to the other means which the QCS depends for raising funds such as donation boxes, as well as receiving to the following account numbers at Qatar International Islamic Bank QA72QIIB000000001111263620001, QA34QIIB000000001111263620006, and on a monthly deduction method.

QATAR Cancer Society (QCS) has launched ‘Be moustache ..check 2 “ campaign to raise awareness about prostate cancer, which is the second most common cancer in men in Qatar and the world, and the fifth biggest cause of deaths in men from cancer globally.

QCS organized awareness lectures and workshops involving various sectors in the country to raise people’s awareness of the symptoms of the disease, the factors responsible for it, as well as methods of prevention and cure of the disease.

‘Worldwide, more than 1 million men are diagnosed with prostate cancer and more than 300,000 die of the disease in 2012. In U.S.A, About 1 man in 7 will be diagnosed with prostate cancer during his lifetime’.

Prostate cancer begins when cells in the prostate gland start to grow uncontrollably. The prostate is a gland found only in males. The prostate is a gland located in the lower urinary tract, under the bladder and around the urethra , he added .

Early prostate cancer usually causes no symptoms. More advanced prostate cancers sometimes cause symptoms. In most cases, symptoms are caused by benign prostatic enlargement, or an infection. Because of this it is important that you see a doctor to understand what causes the symptoms ‘ Problems urinating, including a weak or interrupted urinary flow, pain while urinating, inability to urinate, sense of incompletely emptying the bladder, intense need to urinate, or the need to urinate more often, especially at night , Blood in the urine or semen , Erection problems , Pain in the hips, back (spine), chest (ribs), or other areas from cancer that has spread to bones , Weakness or numbness in the legs or feet, or even loss of bladder or bowel control from cancer pressing on the spinal cord and nerves.

Qatar Cancer Society (QCS) participated in the ‘World Cancer Leader’s Summit organised by Union for International Cancer Control (UICC) in Mexico recently.
The summit, held under the theme ‘Cities driving change’, was attended by a delegation led by QCS Chairman Sheikh Dr Khalid bin Jabor al Thani and was opened by Mexican President Enrique Peña Nieto in the presence of heads of State, ministers of health, city and industry leaders, first ladies, executives from UICC membership organizations and many other influential players from the cancer and health leadership community.
The meet focused on how to partner collectively and support cities in translating the global commitments in cancer prevention and care into national action by 2025.
The Summit was a major annual high-level policy meeting dedicated to furthering global cancer control, bringing together key decision makers from around the world and encouraging timely debate on emerging issues related to cancer. It provides a forum to secure a coordinated, multileveled global response to address the spiraling cancer epidemic.

Sheikh Dr Khalid said,”Our participation in this summit came within the framework of our membership in Union for International Cancer Control, which is one of the largest international institutions stressing the importance of keeping up with the international experience to develop programmes and future plans through participation in all internal and external events.
Participants called for greater response to the burden of cancer at all levels, especially as few of the four billion people living in cities today have access to high quality cancer treatment in high-income countries.

The summit included a meeting between Sheikh Dr Khalid and HRH Princess Dina Mired, president of Union for International Cancer Control (UICC).
Both sides discussed opportunities for Qatar Cancer Society to work more closely with UICC and engage across UICC’s convening, capacity building and advocacy pillars besides defining work plan for engagement at the World Cancer Congress in Kuala Lumpur with a primary role at the WCC in Oman 2020.
They also explore how to leverage national and regional networks in the global fight against cancer in addition to discussing other potential areas of collaboration.
Key objectives of the World Cancer Leaders’ Summit include raising awareness among leading decision makers to ensure cancer is a global health priority, providing a forum to exchange information and innovative ideas on how to reverse the cancer epidemic and ensure a sustainable response, defining compelling messages to support the global call to action against cancer, creating a force which galvanises politicians and policy makers and increases cancer’s visibility on the international public health agenda.